Aeon
PrivateLast Round
Seed
Sep 14, 2026
Total Funding Raised
$9.34M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Aeon operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Seed round in September 2026.
Aeon is a health technology company that provides a preventive healthcare platform using AI-powered check-ups, including whole-body MRI scans, blood biomarker analysis, and genetic testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Precision Medicine, InsurTech, Healthcare Analytics
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aeon Comparables
Compare Aeon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ahead Health | 92% | |
| Echelon Health | 78% | |
| Prenuvo | 78% |
For institutional investors. Book with your work email.
Aeon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 14, 2026 | ||||
| Seed | Jun 4, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aeon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Concentric | Seed |
| EWOR | Seed |
| Calm/Storm Ventures | Seed |
| Kadmos Capital | Seed |
| GoHub Ventures | Seed |
| Arāya Ventures | Seed |
| N & V Capital AG | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 14, 2026
Led by Arāya Ventures with participation from Calm/Storm Ventures, Concentric, GoHub Ventures, and Kadmos Capital.
- May 4, 2026
Grew 17% QoQ, from 23 to 27 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- acquiresSep 15, 2026
Aeon acquires Aware Health for $13.8M in Switzerland on Sep 17th '26, as its total seed funding surpasses €12 million.
- invests_into_assetsSep 14, 2026
On Sep 14th '26, Aeon acquires Aware Health's key assets in Germany, including its technology, network of more than 45 blood-collection sites, and platform for more than 100 biomarkers, alongside a seed extension that brings total seed capital above $14 million, to integrate the assets into its platform and support continuous preventive care.
For institutional investors. Book with your work email.
Aeon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aeon's valuation, stock price, and market status.
Is Aeon a public or private company?
Aeon is a private company.
What is the current stock price of Aeon?
Aeon is a private company, so its shares have no public market price. Caplight tracks Aeon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aeon worth (valuation)?
Valuation information for Aeon is not publicly available.
Can I buy Aeon stock?
Aeon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aeon's last funding round?
Aeon's most recent funding round was Seed on September 14, 2026.
Who are the main investors in Aeon?
Key investors in Aeon include Concentric, Arāya Ventures.
Will Aeon IPO soon?
No public IPO plans have been announced for Aeon.
How can I track Aeon secondary market activity?
Caplight tracks bids, offers, and trades in Aeon's shares on secondary markets.